🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Hui Yang

Hebei Medical University

ORCID: 0000-0002-6125-5985

Also affiliated with Third Hospital of Hebei Medical University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy”.

Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy

Nature Medicine(2022)10.1038/s41591-022-01696-4

N/A

2.2DataRank · unranked

83 citations

Hui Yang, Feiyang Ma, Guillermo Montalban‐Bravo, Natthakan Thongon, Valentina Marchica +33 more

Natural killer cells’ functional impairment drives the immune escape of pre-malignant clones in early-stage myelodysplastic syndromes

Nature Communications(2025)10.1038/s41467-025-58662-0

N/A

0.321DataRank · unranked

7 citations

Irene Gañán‐Gómez, Bijender Kumar, Natthakan Thongon, Feiyang Ma, Kelly S. Chien +35 more

A phase II trial of azacitidine with ipilimumab, nivolumab, or ipilimumab and nivolumab in previously untreated myelodysplastic syndrome

Haematologica(2025)10.3324/haematol.2024.286559

N/A

0.165DataRank · unranked

2 citations

Guillermo Montalban‐Bravo, Koji Sasaki, Naval Daver, Elias Jabbour, Yesid Alvarado +19 more

Aberrant DNA hydroxymethylation reshapes transcription factor binding in myeloid neoplasms

Clinical Epigenetics(2022)10.1186/s13148-022-01297-5

N/A

0DataRank · unranked

5 citations

Tingting Hong, Yue Wei, Lei Guo, Minjung Lee, Hui Yang +10 more

Response to Hypomethylating Agents in Myelodysplastic Syndrome Is Associated With Emergence of Novel TCR Clonotypes

Frontiers in Immunology(2021)10.3389/fimmu.2021.659625

N/A

0DataRank · unranked

17 citations

Patrick K. Reville, Xianli Jiang, Hui Yang, Alexandre Reuben, Jin S. Im +6 more

A Phase II Trial of Azacitidine with Ipilimumab, Nivolumab, or Ipilimumab and Nivolumab with or without Azacitidine in Relapsed or Refractory Myelodysplastic Syndrome

Blood(2024)10.1182/blood-2024-205186

N/A

0DataRank · unranked

0 citations

Guillermo Montalban‐Bravo, Koji Sasaki, Naval Daver, Elias Jabbour, Yesid Alvarado Valero +15 more

Blastemia portrays a poor prognosis in acute leukemia patients with invasive pulmonary aspergillosis

Journal of Infection(2025)10.1016/j.jinf.2025.106535

N/A

0DataRank · unranked

2 citations

Sebastian Wurster, Ying Jiang, Alexandre Bazinet, Hui Yang, Russell E. Lewis +5 more